Health
CanSino coronavirus vaccine shows promise in mid-stage study – The Indian Express
CanSino Coronavirus (Covid-19) Vaccine: The shot was shown to be safe and induced an immune response, according to a study released in the medical journal The Lancet, reinforcing the company’s status as a front-runner in the vaccine race.
By: Bloomberg |
Updated: July 21, 2020 10:50:06 am
A lab worker uses a pipette while trying to isolate the presence of the coronavirus during the swab test process at a laboratory in Amedeo di Savoia hospital in Turin, Italy, on Friday, Feb. 28, 2020. (Bloomberg Photo: Federico Bernini)CanSino Coronavirus (Covid-19) Vaccine: CanSino Biologics Inc.s experimental coronavirus vaccine showed promising results in a mid-stage clinical study, paving the way for the next phase of tests as the Chinese…
-
General24 hours agoZac Lomax released by Eels for ‘opportunities outside NRL’, fuelling speculation of R360 switch
-
General22 hours agoIslam Makhachev claims UFC welterweight belt with dominant win over Jack Della Maddalena
-
General13 hours agoAmbulance response times sluggish despite Tasmanian ramping ‘ban’ promise
-
General22 hours agoIs the Coalition up for the Net Zero fight?